Corporate Legal Counsel
Novartis
Summary
As Corporate Legal Counsel, you will provide practical, business-oriented legal advice on U.S. securities law, public-company disclosure, capital markets and Treasury matters, corporate governance, and strategic transactions. You will partner closely with colleagues across Finance, Treasury, Tax, Investor Relations, Corporate Affairs, and Legal in the United States and globally.
Job description
Job Description Summary
As Corporate Legal Counsel, you will provide practical, business-oriented legal advice on U.S. securities law, public-company disclosure, capital markets and Treasury matters, corporate governance, and strategic transactions. You will partner closely with colleagues across Finance, Treasury, Tax, Investor Relations, Corporate Affairs, and Legal in the United States and globally.
Key Responsibilities
- Advise on compliance with U.S. securities laws and related SEC requirements, including the preparation and review of the Novartis Annual Report on Form 20-F.
- Advise on quarterly, periodic, and ad hoc disclosures, SEC filings, investor communications, and other public disclosures.
- Provide legal counsel on U.S. debt and equity capital markets transactions, including transaction structuring, documentation, due diligence, execution, and related disclosures.
- Advise on intercompany financing arrangements, derivatives, corporate investments, and other U.S. and global Treasury activities.
- Provide legal support for the governance and corporate entity management of Novartis U.S. legal entities, including board and shareholder matters, corporate approvals, and legal entity structuring.
- Support mergers and acquisitions, corporate restructurings, strategic transactions, and other cross-functional initiatives.
- Advise on securities law and disclosure considerations relating to internal and external communications.
- Draft, review, and update corporate policies, guidelines, procedures, and related governance materials.
- Monitor developments in securities law, corporate law, capital markets regulation, and other relevant areas, translating those developments into clear, practical guidance for business partners and Legal colleagues.
- Develop and deliver training on relevant legal, regulatory, and governance matters.
- Leverage artificial intelligence and emerging legal technologies responsibly to enhance legal research, drafting, knowledge management, matter management, and workflow efficiency, while applying appropriate legal judgment, confidentiality, data protection, and governance standards.
Essential Requirements
- J.D. from an accredited U.S. law school.
- Admission in good standing in at least one U.S. jurisdiction, with the ability to become authorized to practice in New Jersey under an applicable limited in-house counsel license.
- 3+ years of relevant legal experience at a law firm, public company, or comparable organization.
- Strong knowledge of U.S. securities laws and public-company disclosure requirements, with experience advising a U.S. domestic issuer, foreign private issuer, or clients subject to comparable reporting obligations.
- Demonstrated experience with debt or equity capital markets transactions and other strategic transactions.
- Working knowledge of Delaware and/or New York corporate law.
- Strong legal drafting, research, analytical, and problem-solving skills.
- Demonstrated interest in and ability to effectively use AI-enabled tools and other legal technologies, with an understanding of the importance of responsible use, confidentiality, accuracy, and appropriate human oversight.
Desirable Requirements
- Experience in the pharmaceutical, biotechnology, or healthcare industry.
- Experience with Treasury operations, derivatives, intercompany financing, corporate restructurings, or legal entity governance.
- Experience applying AI and other legal technologies to legal research, drafting, knowledge management, matter management, or process improvement.
Requirements
- J.D. from an accredited U.S. law school
- Admission in good standing in at least one U.S. jurisdiction
- Ability to become authorized to practice in New Jersey under an applicable limited in-house counsel license
- 3+ years of relevant legal experience at a law firm, public company, or comparable organization
- Strong knowledge of U.S. securities laws and public-company disclosure requirements
- Experience advising a U.S. domestic issuer, foreign private issuer, or clients subject to comparable reporting obligations
- Demonstrated experience with debt or equity capital markets transactions and other strategic transactions
- Working knowledge of Delaware and/or New York corporate law
- Strong legal drafting, research, analytical, and problem-solving skills
- Demonstrated interest in and ability to effectively use AI-enabled tools and other legal technologies
- Understanding of responsible use, confidentiality, accuracy, and appropriate human oversight
Benefits
- Health Insurance
- Life Insurance
- Disability Benefits
- 401(k) Matching
- Paid Time Off
- Vacation
- Personal Days
- Holidays
- Performance-Based Cash Incentive
- Annual Equity Awards
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.